Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_assertion type Assertion NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_head.
- NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_assertion description "[The tumor hypoxia changes induced after bevacizumab treatment were evaluated using optical imaging with a HIF-1-dependent reporter gene using the NCI-H441 human lung adenocarcinoma xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_provenance.
- NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_assertion evidence source_evidence_literature NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_provenance.
- NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_assertion SIO_000772 19735869 NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_provenance.
- NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_assertion wasDerivedFrom befree-20150227 NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_provenance.
- NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_assertion wasGeneratedBy ECO_0000203 NP892602.RAvNpjd1-TKJZBvnD04beko3ywEw3lpx879PzTMcV1fvM130_provenance.